ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
635 hedge funds and large institutions have $27.9B invested in Alexion Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 258 increasing their positions, 197 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
635
Holders Change
+25
Holders Change %
+4.1%
% of All Funds
13.81%
Holding in Top 10
12
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.26%
New
87
Increased
258
Reduced
197
Closed
53
Calls
$218M
Puts
$220M
Net Calls
-$1.87M
Net Calls Change
+$23.6M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$3.35B |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
$221M |
| 3 |
JPMorgan Chase & Co
New York
|
$387M |
| 4 |
Jennison Associates
New York
|
$1.18B |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
$81.9M |
